Even as the poltics of anger and division dominate the headlines and our social media feeds, there's another emotion triggered by politics that can just as damaging: depression. UC Merced Professor's book, "The Sad Citizen," takes a deep dive into how disappointment, grief and loss can demobilize people and ideological groups, pushing them to the sidelines of democracy. He investigates the causes of these emotions and makes suggestions about self-care and a more effective political process.

A new $2.6 million NIH grant will support Penn Engineering and Baylor College of Medicine researchers as they develop safer gene editing tools to treat hypertrophic cardiomyopathy (HCM), a common but often undiagnosed genetic heart disease. Their approach could correct key mutations with high precision, offering hope for a lasting cure.

University of Oregon researchers found wood samples tested lower for levels of bacterial abundance than an empty plastic enclosure used as a control.

To deepen international academic collaboration and enhance the global impact of the journal, Yuan Qing, Party Secretary of the School of Medical Technology at Shanghai Jiao Tong University School of Medicine; Dai Jing, Deputy Director of the Department of Laboratory Medicine at Ruijin Hospital; and Wang Erliang, Director of the Editorial Office of LabMed Discovery (LMD), recently traveled to Europe for a series of academic exchanges. Centered on the core goals of "expanding cooperation, absorbing high-quality manuscript sources, and promoting scientific research projects", the delegation achieved significant outcomes through participation in international conferences, visits to leading institutions, and in-depth academic dialogues—injecting fresh momentum into the journal’s international development.

Mark T. Gladwin, MD, Dean of the University of Maryland School of Medicine announced today that Deanna L. Kelly, PharmD, BCPP,  a Professor of Psychiatry at the University of Maryland School of Medicine, has been named Director of the Maryland Psychiatric Research Center (MPRC) after serving as Interim Director for three years. Dr. Kelly is a internationally recognized clinician-scientist specializing in the advancement of treatments for psychotic disorders and schizophrenia.